1005202-76-5 Usage
Uses
Used in Pharmaceutical Development:
1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-methylis used as a potential active pharmaceutical ingredient for the development of new drugs. Its unique structure may contribute to specific pharmacological activities, offering opportunities for the treatment of various diseases and conditions.
Used in Chemical Research:
1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-methylserves as a valuable research tool in the field of chemical and biological processes. Its complex structure allows scientists to study its interactions with biological systems, potentially leading to a better understanding of molecular mechanisms and the discovery of new therapeutic targets.
Used in Drug Delivery Systems:
1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-methylmay be employed in the development of drug delivery systems to improve the efficacy and bioavailability of pharmaceutical agents. Its unique chemical properties could be harnessed to enhance drug targeting, release, and overall therapeutic outcomes.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-methylis utilized for the synthesis of novel compounds with potential therapeutic applications. Its versatile structure can be modified to create a range of derivatives with diverse biological activities, expanding the scope of drug discovery efforts.
Used in Biochemical Analysis:
1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-methylcan be employed in biochemical analysis to study its interactions with various biomolecules, such as proteins, enzymes, and nucleic acids. Understanding these interactions can provide insights into the molecular mechanisms underlying its potential biological activities and inform the design of more effective therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1005202-76-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,5,2,0 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1005202-76:
(9*1)+(8*0)+(7*0)+(6*5)+(5*2)+(4*0)+(3*2)+(2*7)+(1*6)=75
75 % 10 = 5
So 1005202-76-5 is a valid CAS Registry Number.
1005202-76-5Relevant academic research and scientific papers
GSK-3BETAINHIBITOR
-
Page/Page column 124, (2010/04/23)
For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β with good brain permeability
Saitoh, Morihisa,Kunitomo, Jun,Kimura, Eiji,Iwashita, Hiroki,Uno, Yumiko,Onishi, Tomohiro,Uchiyama, Noriko,Kawamoto, Tomohiro,Tanaka, Toshimasa,Mol, Clifford D.,Dougan, Douglas R.,Textor, Garret P.,Snell, Gyorgy P.,Takizawa, Masayuki,Itoh, Fumio,Kori, Masakuni
experimental part, p. 6270 - 6286 (2010/03/24)
Glycogen synthase kinase 3β (GSK-3β) inhibition is expected to be a promising therapeutic approach for treating Alzheimer's disease. Previously we reported a series of 1,3,4-oxadiazole derivatives as potent and highly selective GSK-3β inhibitors, however,
